A carregar...
Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series
BACKGROUND: Brain metastases are common in advanced melanoma and often necessitate corticosteroids such as dexamethasone to control symptoms and reduce peritumoral edema. Immunotherapy improves survival in metastatic melanoma, but concomitant treatment with corticosteroids may reduce efficacy. Here,...
Na minha lista:
| Publicado no: | Health Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6427059/ https://ncbi.nlm.nih.gov/pubmed/30937392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hsr2.115 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|